Pharmaceutical - Respiratory and Pulmonary, Pharmaceutical

Filter

Popular Filters

1 to 25 of 314 results

Boehringer’s Ofev approved in EU for the treatment of IPF

19-01-2015

German family-owned pharma major Boehringer Ingelheim revealed today that the European Commission has…

Boehringer IngelheimEuropeOfevPharmaceuticalRegulationRespiratory and Pulmonary

Boehringer Ingelheim enters research pact with Yale University

Boehringer Ingelheim enters research pact with Yale University

14-01-2015

German family-owned pharma major Boehringer Ingelheim has entered into a collaboration with Yale University,…

Boehringer IngelheimGermanyImmunologicalsOncologyPharmaceuticalResearchRespiratory and Pulmonary

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

08-01-2015

Swiss drug major Novartis today announced positive top-line results from the pivotal Phase III clinical…

MedicineNovartisPharmaceuticalQVA149ResearchRespiratory and PulmonaryUSAVecturaVectura Group

Bristol-Myers Squibb enters global research accord with Calibr

06-01-2015

US pharma major Bristol-Myer Squibb has signed a worldwide research collaboration with the California…

Bristol-Myers SquibbGlobalLicensingPharmaceuticalResearchRespiratory and Pulmonary

PhRMA releases new report on challenges to developing new hepatitis C treatments

PhRMA releases new report on challenges to developing new hepatitis C treatments

19-12-2014

The Pharmaceutical Research and Manufacturers of America released a new report examining the scientific…

Manufacturers of AmericaPharmaceuticalPhRMAResearchRespiratory and Pulmonary

Verona Pharma appoints Kenneth Newman to newly-created chief medical officer position

Verona Pharma appoints Kenneth Newman to newly-created chief medical officer position

18-12-2014

Respiratory disease specialist Verona Pharma has appointed Kenneth Newman to the newly-created chief…

BoardroomPharmaceuticalRespiratory and PulmonaryUKVerona Pharma

GlaxoSmithKline files for EU extended indication for Volibris in PAH

GlaxoSmithKline files for EU extended indication for Volibris in PAH

11-12-2014

UK pharma major GlaxoSmithKline says it has filed a regulatory submission to the European Medicines Agency…

EuropeGilead SciencesGlaxoSmithKlineLetairisPharmaceuticalRegulationRespiratory and PulmonaryVolibris

Meda and Cipla sue Apotex to enforce Dymista patents

Meda and Cipla sue Apotex to enforce Dymista patents

04-12-2014

Swedish pharma company Meda Pharmaceuticals and Indian drugmaker Cipla today have sued Canada-headquartered…

ApotexCiplaDymistaLegalMedaPharmaceuticalRespiratory and PulmonaryUSA

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

02-12-2014

The global chronic obstructive pulmonary disease and asthma devices market is expected to reach $34 billion…

Dosage formsMarkets & MarketingMedicinePharmaceuticalRespiratory and Pulmonary

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

01-12-2014

UK oral and inhalation drug specialist Skyepharma says that, following regulatory approval and agreement…

AbriffFinancialFlutiformItalyJapanKyorin PharmaceuticalMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharmaSpainZambon

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

25-11-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaDuaklir GenuairPharmaceuticalRegulationRespiratory and PulmonaryUK

More November EMA/CHMP recommendations

22-11-2014

A total of 10 new medicines have been recommended for approval at the November 2014 meeting of the European…

apremilastBoehringer IngelheimCelgene Corp.DermatologicalsEuropeNephrology and HepatologyNeurologicalnintedanibOfevOtezlaPharmaceuticalRasagilineRegulationRespiratory and PulmonarySanofiShionogiTeva Pharmaceutcal Industries

AstraZeneca reinforces target of $45 billion revenues by 2023

AstraZeneca reinforces target of $45 billion revenues by 2023

18-11-2014

Anglo-Swedish pharma major AstraZeneca today provided an update for institutional investors and financial…

AstraZenecaCardio-vascularFinancialInflammatory diseasesMetabolicsOncologyPharmaceuticalRespiratory and PulmonaryUK

ALK Abello reports positive financials for third quarter with sales up 3%

ALK Abello reports positive financials for third quarter with sales up 3%

14-11-2014

Denmark-based allergy specialist ALK Abello has reported positive results for the third quarter of 2014.

ALK AbelloDenmarkFinancialGrazaxPharmaceuticalRespiratory and Pulmonary

GlaxoSmithKline invests in Australia plant expansion

14-11-2014

UK pharma major GlaxoSmithKline’s Australian subsidiary today announced it will be investing A$31 million…

AustraliaFinancialGlaxoSmithKlinePharmaceuticalProductionRespiratory and PulmonaryVentolin HFA

GSK COPD survey shows many sufferers underestimate the severity of their condition

GSK COPD survey shows many sufferers underestimate the severity of their condition

12-11-2014

UK pharma major GlaxoSmithKline has conducted a global survey of people living with chronic obstructive…

GlobalGSKPharmaceuticalResearchRespiratory and PulmonaryUnited States

Positive results for Sanofi/Regeneron’s dupilumab in asthma

Positive results for Sanofi/Regeneron’s dupilumab in asthma

11-11-2014

French pharma major Sanofi and US partner Regeneron Pharmaceuticals have released positive results from…

dupilumabFrancePharmaceuticalRegeneron PharmaceuticalsResearchRespiratory and PulmonarySanofi

Vectura gets VR315 US development milestone

07-11-2014

UK inhaled therapies developer Vectura Group says that it has triggered a further milestone associated…

FinancialPharmaceuticalResearchRespiratory and PulmonaryVectura GroupVR315

Janssen collaborating International Union Against Tuberculosis and Lung Disease on Sirturo study

Janssen collaborating International Union Against Tuberculosis and Lung Disease on Sirturo study

06-11-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary is to collaborate with the International…

bedaquilineJanssenPharmaceuticalResearchRespiratory and PulmonarySirturo

Boehringer Ingelheim's Spiriva Respimat NDA for asthma accepted for review by FDA

Boehringer Ingelheim's Spiriva Respimat NDA for asthma accepted for review by FDA

04-11-2014

German family-owned drug major Boehringer Ingelheim has had its Spiriva Respimat (tiotropium bromide)…

Boehringer IngelheimGermanyPharmaceuticalRegulationRespiratory and PulmonarySpirivaSpiriva Respimat

Almirall transfers rights to respiratory business to AstraZeneca

Almirall transfers rights to respiratory business to AstraZeneca

03-11-2014

Spanish pharma company Almirall has transferred the rights to its respiratory franchise to Anglo-Swedish…

AlmirallAstraZenecaEkliraPharmaceuticalResearchRespiratory and PulmonarySpain

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

1 to 25 of 314 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top